EU regulators fine J&J, Novartis 16 mln euros for generic drug deal | Business Information & News | Westlaw

EU regulators fine J&J, Novartis 16 mln euros for generic drug deal | Business Information & News | Westlaw

View on Westlaw or start a FREE TRIAL today, EU regulators fine J&J, Novartis 16 mln euros for generic drug deal, Business Information & News
12/11/13 REUTERS 11:00:00
REUTERS
Copyright © 2013 Thomson Reuters
December 11, 2013
EU regulators fine J&J, Novartis 16 mln euros for generic drug deal
By Foo Yun Chee
BRUSSELS (Reuters) - European Union antitrust regulators fined drugmakers Johnson & Johnson and Novartis a total of 16 million euros ($21.95 million) on Tuesday for blocking the sale of a generic painkiller in the Dutch market.
The...
---- Index References ----
Company: NOVARTIS INC; SANDOZ INC; JOHNSON AND JOHNSON
News Subject: (World Organizations (1IN77); European Union (1EU94); EU News (1EU58); Major Corporations (1MA93))
Industry: (Pharmaceuticals Cost-Benefits (1PH30); Healthcare (1HE06); Pharmaceuticals (1PH33); Generic Drugs (1GE93); Pharmaceuticals & Biotechnology (1PH13); Medical Equipment & Supplies (1HE68))
Region: (Europe (1EU83))
Language: EN
Other Indexing: (Joaquin Almunia)
Keywords: antitrust; health (MCC:OEC); (N2:US); (N2:AMERS); (N2:USA); (MCCL:OVR); (MCCL:OEC)
Word Count: 200
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.